Rozanolixizumab

3 trials 2 recruiting LOncology Orphan designation

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

2 Recruiting

1 Completed trials

1 Sponsors

10 Countries

Phase III

Phase II/III

Phase III: 2 Phase II/III: 1

Indications tested

Myasthenia gravis 2

Sponsors using this IMP

UCB Biopharma 3

All trials

3 total

An extension study to find out if multiple treatment cycles of rozanolixizumab are safe and work in children with myasthenia gravis Recruiting

2022-502075-34-00 Phase III 2 countries UCB Biopharma
A study to learn if rozanolixizumab is safe, how it moves through the body, and if it works in children with myasthenia gravis Recruiting

2022-502074-16-00 Phase II/III 2 countries UCB Biopharma
A study to learn if Rozanolixizumab works and is safe over a long period in adults with relapsing myelin oligodendrocyte glycoprotein antibo… Ended

2023-509237-39-00 Phase III 10 countries UCB Biopharma

Showing 1–3 of 3 trials

← All drugs A–Z